Cargando…

Cell type-specific abnormalities of central nervous system in myotonic dystrophy type 1

Myotonic dystrophy type 1 is a multisystem genetic disorder involving the muscle, heart and CNS. It is caused by toxic RNA transcription from expanded CTG repeats in the 3′-untranslated region of DMPK, leading to dysregulated splicing of various genes and multisystemic symptoms. Although aberrant sp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamori, Masayuki, Shimizu, Hiroshi, Ogawa, Kotaro, Hasuike, Yuhei, Nakajima, Takashi, Sakurai, Hidetoshi, Araki, Toshiyuki, Okada, Yukinori, Kakita, Akiyoshi, Mochizuki, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218787/ https://www.ncbi.nlm.nih.gov/pubmed/35770133 http://dx.doi.org/10.1093/braincomms/fcac154

Ejemplares similares

Cellular Senescence and Aging in Myotonic Dystrophy
por: Hasuike, Yuhei, et al.
Publicado: (2022)

Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model Cells
por: Hasuike, Yuhei, et al.
Publicado: (2022)

Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability
por: Ueki, Junko, et al.
Publicado: (2017)

Oral administration of erythromycin decreases RNA toxicity in myotonic dystrophy
por: Nakamori, Masayuki, et al.
Publicado: (2015)

Pharmacotherapy alleviates pathological changes in human direct reprogrammed neuronal cell model of myotonic dystrophy type 1
por: Eltahir, Mougina K., et al.
Publicado: (2022)

Detection of Slipped-DNAs at the Trinucleotide Repeats of the Myotonic Dystrophy Type I Disease Locus in Patient Tissues
por: Axford, Michelle M., et al.
Publicado: (2013)

Deregulations of miR‐1 and its target Multiplexin promote dilated cardiomyopathy associated with myotonic dystrophy type 1
por: Souidi, Anissa, et al.
Publicado: (2023)

Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
por: Finsterer, Josef, et al.
Publicado: (2017)

Sleep Disorders in Four Patients With Myotonic Dystrophy Type 1
por: Urata, Yuka, et al.
Publicado: (2020)

Disease burden of myotonic dystrophy type 1
por: Landfeldt, Erik, et al.
Publicado: (2019)

Myotonic dystrophy type 2: the 2020 update
por: Meola, Giovanni
Publicado: (2020)

Cardiac Pathology in Myotonic Dystrophy Type 1
por: Mahadevan, Mani S., et al.
Publicado: (2021)

Targeting Myotonic Dystrophy Type 1 with Metformin
por: García-Puga, Mikel, et al.
Publicado: (2022)

TNNT2 Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2
por: Bosè, Francesca, et al.
Publicado: (2019)

Targeting nuclear RNA for in vivo correction of myotonic dystrophy
por: Wheeler, Thurman M., et al.
Publicado: (2012)

Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1
por: Winkler, Nelson S., et al.
Publicado: (2018)

Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2
por: Cardani, Rosanna, et al.
Publicado: (2013)

Straightjacket/α2δ3 deregulation is associated with cardiac conduction defects in myotonic dystrophy type 1
por: Auxerre-Plantié, Emilie, et al.
Publicado: (2019)

Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy
por: Thomas, James D., et al.
Publicado: (2017)

Myotonic Dystrophy Type 1 Presenting as Male Infertility
por: Kim, Woong Bin, et al.
Publicado: (2012)

Deregulated MicroRNAs in Myotonic Dystrophy Type 2
por: Greco, Simona, et al.
Publicado: (2012)

Hypogonadism and erectile dysfunction in myotonic dystrophy type 1
por: PERIC, STOJAN, et al.
Publicado: (2013)

Prevalence and correlates of apathy in myotonic dystrophy type 1
por: Gallais, Benjamin, et al.
Publicado: (2015)

Imaging in Myotonic Dystrophy Type 1 – Case Reports
por: Bielen, Jurgen, et al.
Publicado: (2016)

Metabolic impairments in patients with myotonic dystrophy type 2
por: VUJNIC, MILORAD, et al.
Publicado: (2018)

Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1
por: Voellenkle, Christine, et al.
Publicado: (2019)

Personality traits in patients with myotonic dystrophy type 2
por: Paunic, Teodora, et al.
Publicado: (2017)

Responsiveness of outcome measures in myotonic dystrophy type 1
por: Knak, Kirsten L., et al.
Publicado: (2020)

Endometriosis as Initial Manifestation of Myotonic Dystrophy Type-2
por: Finsterer, Josef, et al.
Publicado: (2021)

Basilar Artery Dissection in Myotonic Dystrophy Type 1
por: Lee, Chan-Hyuk, et al.
Publicado: (2022)

Benefits of aerobic exercise in myotonic dystrophy type 1
por: Mackenzie, Samuel J., et al.
Publicado: (2022)

Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2
por: Peric, Stojan, et al.
Publicado: (2022)

Myotonic dystrophy type 1 in the COVID-19 era
por: Ilic Zivojinovic, Jelena, et al.
Publicado: (2023)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1
por: Simoncini, Costanza, et al.
Publicado: (2020)

Fluid Biomarkers of Central Nervous System (CNS) Involvement in Myotonic Dystrophy Type 1 (DM1)
por: Rossi, Salvatore, et al.
Publicado: (2023)

Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2
por: Timchenko, Lubov
Publicado: (2022)

Quercetin selectively reduces expanded repeat RNA levels in models of myotonic dystrophy
por: Mishra, Subodh K., et al.
Publicado: (2023)

Establishment of quantitative and consistent in vitro skeletal muscle pathological models of myotonic dystrophy type 1 using patient-derived iPSCs
por: Kawada, Ryu, et al.
Publicado: (2023)

Depression in Myotonic Dystrophy type 1: clinical and neuronal correlates
por: Winblad, Stefan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vaukhejocm8fc1knjkklt35tab